January 8, 2013
By:
Jennifer Markarian
Eli Lilly expects overall revenue growth in the coming year.
|
January 8, 2013
By:
Adeline Siew, PhD
Shire has signed an agreement to acquire Lotus Tissue Repair, Inc., a biotechnology company developing the first and only protein replacement therapy for the orphan disease, dystrophic epidermolysis bullosa (DEB).
|
January 7, 2013
By:
Stephanie Sutton
The PATH Malaria Vaccine Initiative and Inovio Pharmaceuticals have announced a follow-on collaboration to advance the development of malaria vaccines and new vaccine delivery technologies.
|
January 7, 2013
By:
Adeline Siew, PhD
Janssen Pharmaceuticals, Inc. and GlycoVaxyn AG have entered into a three-year agreement to collaborate on the research and development of a multivalent bacterial vaccine utilizing GlycoVaxyn's bio-conjugation technology.
|
January 7, 2013
By:
Amy Ritter, PhD
AbbVie, a research-focused, specialty biopharmaceutical company that was spun off from Abbott Pharmaceuticals, was officially launched on Jan. 2, 2013.
|
January 2, 2013
By:
Patricia Van Arnum
Additional approvals in December have helped to outpace a recent high set in 2011.
|
December 31, 2012
By:
Stephanie Sutton
The management board of the European Medicines Agency (EMA) has endorsed the agency?s work programme and budget for 2013, which includes a budget of EUR231.6 million, a slight increase over 2012.
|
December 31, 2012
By:
Amy Ritter, PhD
Amgen has agreed to pay $762 million to resolve criminal liability and false claims act allegations.
|
December 24, 2012
By:
Adeline Siew, PhD
Mylan Inc. has issued a recall of three lots of the painkiller tablets, hydrocodone bitartrate and acetaminophen, USP 10 mg/500 mg, due to the potential risk that these lots (lots 3037841, 3040859 and 3042573) may exceed the potency stated on the label.
|
|
